Alkermes Inc. plc (ALKS)

$

9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
.
9
8
7
6
5
4
3
2
1
0
0
$0.11 (-0.35%)Past DayToday's Volume:
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
,
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0

About

Business overview of Alkermes Inc. plc (ALKS)
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.

Key Insights

Critical company metrics and information
  • Share Price

    $31.18
  • Market Cap

    $5.04 Billion
  • Total Outstanding Shares

    161.80 Million Shares
  • Total Employees

    2,100
  • Dividend

    No dividend
  • IPO Date

    July 16, 1991
  • SIC Description

    Pharmaceutical Preparations
  • Homepage

    https://www.alkermes.com

Historical Stock Splits

Execution DateSplit Amount
No Historical Stock Splits

Cash Flow Statement

October 1, 2023 to September 30, 2024
MetricValue
Net Cash Flow From Financing Activities$-488.97 Million
Net Cash Flow From Operating Activities, Continuing$355.96 Million
Net Cash Flow From Investing Activities, Continuing$-118.42 Million
Net Cash Flow From Financing Activities, Continuing$-488.97 Million
Net Cash Flow From Operating Activities$355.96 Million
Net Cash Flow From Investing Activities$-118.42 Million
Net Cash Flow, Continuing$-251.42 Million
Net Cash Flow$-251.42 Million

Income Statement

October 1, 2023 to September 30, 2024
MetricValue
Operating Income/Loss$312.58 Million
Net Income/Loss Available To Common Stockholders, Basic$333.35 Million
Cost Of Revenue$253.34 Million
Income/Loss From Continuing Operations Before Tax$332.18 Million
Other Operating Expenses$10.08 Million
Research and Development$261.08 Million
Income Tax Expense/Benefit, Deferred$-20.20 Million
Gross Profit$1.25 Billion
Basic Average Shares$166.77 Million
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic$0.00
Net Income/Loss Attributable To Parent$333.35 Million
Diluted Average Shares$168.94 Million
Benefits Costs and Expenses$1.17 Billion
Operating Expenses$939.20 Million
Selling, General, and Administrative Expenses$668.03 Million
Income Tax Expense/Benefit$-54.78 Million
Basic Earnings Per Share$2.00
Net Income/Loss Attributable To Noncontrolling Interest$0.00
Net Income/Loss$333.35 Million
Revenues$1.51 Billion
Preferred Stock Dividends And Other Adjustments$0.00
Income/Loss From Discontinued Operations Net Of Tax$-53.61 Million
Nonoperating Income/Loss$19.60 Million
Income/Loss From Continuing Operations After Tax$386.95 Million
Costs And Expenses$1.19 Billion
Diluted Earnings Per Share$1.98

Balance Sheet

October 1, 2023 to September 30, 2024
MetricValue
Other Current Liabilities$360.76 Million
Equity Attributable To Noncontrolling Interest$0.00
Equity Attributable To Parent$1.29 Billion
Noncurrent Liabilities$409.48 Million
Other Non-current Assets$365.69 Million
Noncurrent Assets$591.11 Million
Wages$55.90 Million
Accounts Payable$37.04 Million
Liabilities$863.18 Million
Accounts Receivable$367.21 Million
Liabilities And Equity$2.16 Billion
Assets$2.16 Billion
Fixed Assets$225.42 Million
Equity$1.29 Billion
Current Liabilities$453.70 Million
Inventory$191.09 Million
Current Assets$1.56 Billion
Other Current Assets$1.01 Billion

Historical Dividends

Announcement DatePayment DateRecord DateAmountFrequency
No historical dividends

Related Companies

View additional S&P 500 companies similar to Alkermes Inc. plc (ALKS)
Boost your savings and earn 4.35% APY with a Marcus by Goldman Sachs savings account, a rate that's 8x the national averagewhen signing up with Financhle. No fees, no minimum deposits, backed by the financial expertise of Goldman Sachs. Terms apply.